Adalimumab as therapy for fistulizing orofacial Crohn's disease.
Doherty
Glen
G
Kalachand
Roshni
R
Patchett
Stephen
S
D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002610:Cheek; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D017577:Cutaneous Fistula / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male; D016155:Oral Fistula / Q000188:drug therapy / Q000209:etiology*; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab